Form 4: NeueHealth Executive Tomas Orozco Acquires Shares Through Vesting of Restricted Stock Units

EVP of Consumer Care at NeueHealth, Tomas Orozco, acquired 3,971 shares of common stock through the vesting of restricted stock units.

Summary

• Tomas Orozco, EVP of Consumer Care at NeueHealth, acquired 3,971 shares of common stock on January 3, 2025.
• This acquisition was a result of the vesting of restricted stock units.
• The restricted stock units vested on January 3, 2025, two years after the grant date.
• Each restricted stock unit represents the right to receive one share of NeueHealth's common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed as neutral to slightly positive. It indicates alignment of executive interests with shareholders.

Positives

• The vesting of restricted stock units indicates a long-term commitment by the executive to the company's success.
• The acquisition of shares increases the executive's stake in the company.

Industry Context

This is a standard SEC Form 4 filing, which is common for executives who receive stock-based compensation. It reflects the normal course of business for publicly traded companies.

Comparison to Industry Standards

• The vesting of restricted stock units is a common practice for executive compensation in publicly traded companies.
• Similar filings are made by executives at companies like UnitedHealth Group (UNH) and CVS Health (CVS) when they acquire shares through stock options or restricted stock units.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with the company's performance.

Key Dates

Keywords

NeueHealth, stock, restricted stock units, vesting, executive, insider trading, Form 4, Tomas Orozco